Keywords: PRRT; Neuroendocrine tumor; Peptide receptor radionuclide therapy; NETTER-1; Carcinoid;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NET; Biomarker; Imaging; Somatostatin analogues; Chemotherapy; PRRT; Targeted agents;
Keywords: 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: Aggressive adenomas; Chemotherapy; Endoscopic endonasal approach; Multidisciplinary management; Pituitary tumors; Radiotherapy; ACTH; Adrenocorticotrophic hormone; DTPA; Diethylenttriaminepentacetate; GH; Growth hormone; MRI; Magnetic resonance imaging; P
Keywords: neuroendocrine tumours; PRRT; radionuclides; somatostatin receptor
Keywords: Neuroendocrine tumor; Carcinoid; Radionuclide therapy; PRRT; Treatment;
Keywords: 90Y-DOTATOC; Peptide receptor radionuclide therapy; PRRT; Neuroendocrine tumors; Dosimetry;
Keywords: Bone marrow; Bronchopulmonary; Carcinoid; Gastroenteropancreatic neuroendocrine tumor; Hepatic neuroendocrine metastasis; Peptide receptor radionuclide therapy; PRRT; Renal toxicity;
Effect of image registration on 3D absorbed dose calculations in 177Lu-DOTATOC peptide receptor radionuclide therapy
Keywords: Deformable image registration; Dosimetry; Dose calculation; PRRT;
General ReviewPeptide receptor radionuclide therapy of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): From literature to practiceRadiothérapie interne vectorisée par les peptides des tumeurs neuroendocrines gastro-entéro-pancréatiques (TNE-G
Keywords: Neuroendocrine tumors; PRRT; 177Lu-octreotate; Somatostatin analogs; Chemotherapy; Targeted therapy; Yttrium-90; Tumeurs neuroendocrines; Radiothérapie interne vectorisée; 177Lu-octreotate; Somatostatine; Chimiothérapie; Thérapies ciblées; Yttrium-90
Management of a metastasized high grade insulinoma (G3) with refractory hypoglycemia: Case report and review of the literature
Keywords: Malignant insulinoma; G3; Refractory hypoglycemia; Neuroendocrine pancreatic tumor; Liver directed therapies; PRRT;
Patient Selection for Personalized Peptide Receptor Radionuclide Therapy Using Ga-68 Somatostatin Receptor PET/CT
Keywords: Ga-68; PRRT; Somatostatin receptors;
PET imaging and biodistribution analysis of the effects of succinylated gelatin combined with l-lysine on renal uptake and retention of 64Cu-cyclam-RAFT-c(-RGDfK-)4in vivo
Keywords: PET; positron emission tomography; GF; Gelofusine; Lys; l-lysine; Radio-TLC; radio-thin-layer chromatography; RAFT; Regioselectively Addressable Functionalized Template; cRGD; cyclic pentapeptide containing the tripeptide sequence Arg-Gly-Asp; cyclam; 1,4
Peptide receptor radionuclide therapy of neuroendocrine tumors with 90Y-DOTATOC: Is treatment response predictable by pre-therapeutic uptake of 68Ga-DOTATOC?
Keywords: PRRT; Neuroendocrine tumor; 68Ga-DOTATOC; 90Y-DOTATOC; PET/CT
New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts
Keywords: uPAR; PRRT; in vivo; 177Lu; Imaging;
Influence of cations on the complexation yield of DOTATATE with yttrium and lutetium: a perspective study for enhancing the 90Y and 177Lu labeling conditions
Keywords: 90Y-DOTATATE; 177Lu-DOTATATE; Cationic metals; PRRT
The Management of Neuroendocrine Tumours: Current and Future Medical Therapy Options
Keywords: CgA; neuroendocrine tumours; octreotide; PRRT; somatostatin analogues; TNM staging;
13Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
Keywords: Neuroendocrine tumours; Lutetium; Yttrium; Peptide receptor radionuclide therapy; PRRT; Somatostatin analogues;
Improved synthesis and biological evaluation of chelator-modified α-MSH analogs prepared by copper-free click chemistry
Keywords: Copper free click chemistry; Cyclooctyne; Peptide synthesis; Gallium-68; Copper-64; Melanocyte stimulating hormone; Molecular imaging; PET; Radionuclide therapy; PRRT
Treatment of high-grade glioma with radiolabeled peptides
Keywords: Radiolabeled peptides; PRRT; High-grade glioma; Glioblastoma; Treatment
Malignant pheochromocytomas and paragangliomas – The importance of a multidisciplinary approach
Keywords: Pheochromocytoma; Paraganglioma; Adrenal mass; Multi-modality imaging; MIBG; SSTR; PRRT
Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs
Keywords: β-Ala; β-alanine; Bn; bombesin; BRS-3; bombesin receptor subtype 3; BSA; bovine serum albumin fraction V; CNS; central nervous system; DMEM; Dulbecco's minimum essential medium; FBS; fetal bovine serum; GI; gastrointestinal; GRP; gastrin-releasing pepti
Tumor uptake of 68Ga-DOTA-Tyr3-octreotate: animal PET studies of tumor flow and acute somatostatin receptor modulation in the CA20948 rat model
Keywords: Gallium 68; Octreotide; PRRT; DOTA-Tyr3-octreotate; CA20948 tumor
Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy
Keywords: Somatostatin Analogs; Somatostatin Receptors; Peptide Radio Receptor Therapy; DOTATOC; [DOTA0,Tyr3]-octreotide; DOTATATE; [DOTA0,Tyr3,Thr8]-octreotide; DTPA; diethylenetriaminepentaacetic acid; GEP-NET; gastroenteropancreatic neuroendocrine tumor; IFN; in
The History and Development of the Gastroenteropancreatic Endocrine Axis
Keywords: Gastroenteropancreatic endocrine axis; Hormones; Secretin; Insulin; Somatostatin; Somatostatin analogs; PRRT;
On the preparation of a therapeutic dose of 177Lu-labeled DOTA–TATE using indigenously produced 177Lu in medium flux reactor
Keywords: PRRT; 177Lu; DOTA–TATE; Somatostatin receptors